Neurosense Therapeutics Ltd. (NRSN) Live Share Price, Invest From India

Neurosense Therapeutics Ltd. Stock Performance

as on October 2, 2026 at 5:07 am IST

Day's High
$4.00
Day's Price Range
$4.37
$4.00
9.25%
Upside
52 Week's High
$4.00
52-Week Price Range
$26.64
$4.00
565.95%
Upside

Neurosense Therapeutics Ltd. share price movements today

Previous Close: $4.43
Open: $4.37
Volume: 217.5K
Market Cap: $9.1M
Day's Low - High: $4.00 - $4.37
52 Week Low - High: $4.00 - $26.64

Neurosense Therapeutics Ltd. Historical Returns

1 Month Return: -47.27 %
3 Month Return: -69.36 %
1 Year Return: -82.14 %
3 Year Return: -68.8 %
5 Year Return: 0 %

Neurosense Therapeutics Ltd. Stock Fundamentals & Key Indicators

Check Neurosense Therapeutics Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.1M

EPS (TTM)

-8.908

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.55

Industry PE ratio

-4.09

PEG Ratio

-0.15

EBITDA

-11.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

1070.23%

Neurosense Therapeutics Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neurosense Therapeutics Ltd. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Neurosense Therapeutics Ltd.	Buy	$9.1M	NA	-0.55	0.00%	0.00%
Revolution Medicines	StrongBuy	$43.8B	604.88%	-22.69	0.00%	0.00%
Moderna	Neutral	$81.2B	-43.54%	-24.76	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$133.4B	189.75%	30.38	86.04%	0.00%
Regeneron	Buy	$77.3B	32.85%	17.79	84.86%	0.49%

Stock Returns calculator for Neurosense Therapeutics Ltd. Stock including INR - Dollar returns

The Neurosense Therapeutics Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Neurosense Therapeutics Ltd. investment value today

Current value as on today

₹17,517

Returns

-₹82,483

(-82.48%)

Returns from Neurosense Therapeutics Ltd. Stock

-₹83,871 (-83.87%)

Dollar Impact

₹1,388 (+1.39%)

Analyst Recommendation on Neurosense Therapeutics Ltd. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Neurosense Therapeutics Ltd.. Average target price of $97.33

Neurosense Therapeutics Ltd. Share Price Target

Get share price movements and forecasts by analysts on Neurosense Therapeutics Ltd..

What analysts predicted

95.89%UPSIDE

Target Price

$97.33

Current Price

Analyzed by

8 Analysts

Target

$97.33

Neurosense Therapeutics Ltd. target price $97.33, a slight upside of 95.89% compared to current price of $4. According to 8 analysts rating.

Indian Investors' Interest in Neurosense Therapeutics Ltd. Stock

Search interest for Neurosense Therapeutics Ltd. Stock has increased by 380% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 1, 2026 to October 1, 2026

Change:380% versus previous 30 day period

Neurosense Therapeutics Ltd. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-2	-3	-2	-2	-3	-2	-2	-2	-3	-3
EBITDA	-2	-5	2	-2	0	-2	-2	-2	-3	-3
Interest Expense	0	0	0	2	-	0	0	0	-	-
Depreciation	0	0	-	0	0	0	0	0	0	0
Income Before Tax	-2	-5	0	-5	0	-2	-2	-2	-3	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-2	-5	0	-5	0	-2	-2	-2	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Neurosense Therapeutics Ltd. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Mar 2024	Mar 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	-	-	-
Operating Income	-1	-2	-5	-13	-12	-9	-11
EBITDA	-1	-2	-2	-12	-9	-9	-11
Interest Expense	0	-	1	0	0	0	-
Depreciation	1	0	0	0	0	0	0
Income Before Tax	-1	-2	-4	-12	-10	-10	-11
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-1	-2	-4	-12	-10	-10	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Neurosense Therapeutics Ltd. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Net Income	0	0	0	0	0	0	0	-3	-3
Operating Cash Flow	-	-	-	-	-	-	-	-1	-1
Investing Cash Flow	-	-	-	-	-	-	-	0	0
Financing Cash Flow	-	-	-	-	-	-	-	1	1
Change in Cash	-2	5	-2	-	-	-	-	0	0

Neurosense Therapeutics Ltd. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Mar 2024	Mar 2025	Mar 2026
Net Income	-1	-2	-4	-12	-10	-10	-11
Operating Cash Flow	0	0	-1	-7	-8	-10	-7
Investing Cash Flow	0	0	0	-3	3	0	0
Financing Cash Flow	1	0	11	3	3	10	4
Change in Cash	0	0	10	-7	0	0	-3

Global Institutional Holdings in Neurosense Therapeutics Ltd.

Check out the Institutions with significant holdings in Neurosense Therapeutics Ltd..

Funds	Holdings
Fidelity Concord Street Trust	0.84%

Insights on Neurosense Therapeutics Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 597.7% return, outperforming this stock by 679.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 86.4% return, outperforming this stock by 155.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, NRSN stock has moved down by -40.1%

About Neurosense Therapeutics Ltd.

NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.

Organisation	Neurosense Therapeutics Ltd.
Headquarters	Building B, Herzliya, TA, 4672562, IL
Industry	Biotechnology
CEO	Alon Ben-Noon

Key Management of Neurosense Therapeutics Ltd.

Name	Title
Mr. Alon Ben-Noon	Co-Founder, CEO & Director
Mr. Or Eisenberg	Chief Financial Officer
Dr. Niva Russek-Blum Ph.D.	Chief Technology Officer

FAQs

What is Neurosense Therapeutics Ltd. share price today?

Neurosense Therapeutics Ltd. share price today is $4.00 as on October 1, 2026 at 11:37 pm IST. Neurosense Therapeutics Ltd. share today touched a day high of $4.37 and a low of $4.00.

What is the 52 week high and 52 week low for Neurosense Therapeutics Ltd. share?

Neurosense Therapeutics Ltd. share touched a 52 week high of $26.64 on October 21, 2025 and a 52 week low of $4.00 on September 30, 2026. Neurosense Therapeutics Ltd. stock price today i.e. October 1, 2026 at 11:37 pm IST is trending at $4.00,which is 84.98% down from its 52 week high and 0.00% up from its 52 week low.

What is Neurosense Therapeutics Ltd.'s market capitalisation today?

Neurosense Therapeutics Ltd. market capitalisation is $0.00T as on October 1, 2026 at 11:37 pm IST.

How to invest in Neurosense Therapeutics Ltd. Stock (NRSN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neurosense Therapeutics Ltd. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Neurosense Therapeutics Ltd. Stock (NRSN) from India?

Indian investors can start investing in Neurosense Therapeutics Ltd. (NRSN) shares with as little as ₹96.315002441406 or $1 (as of October 1, 2026 at 11:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.15 in Neurosense Therapeutics Ltd. stock (as per the Rupee-Dollar exchange rate as on October 1, 2026 at 11:40 pm IST). Based on Neurosense Therapeutics Ltd. share’s latest price of $4.00 as on October 1, 2026 at 11:37 pm IST, you will get 2.5000 shares of Neurosense Therapeutics Ltd.. Learn more about fractional shares .